Search | IOVS | ARVO Journals

View

Showing 1 – 20 of 56

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract May 2006

Retinal Vascular Permeability Is Regulated by VEGFR1 and VEGFR2

W. Xiao; S.A. Vinores; D. Collen; P. Carmeliet; P.A. Campochiaro

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):503. doi:

ARVO Annual Meeting Abstract May 2006

Evaluation of the Retina of Subjects Without Diabetes Mellitus and Subjects With Diabetes Mellitus Without Diabetic Retinopathy Using Optical Coherence Tomography

A.H. Kashani; S.M. Shah; J. Haller; E.S. West; I. Zimmer–Galler; J.U. Sung; E. Quinlan; D.V. Do; P.A. Campochiaro; Q.D. Nguyen

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):1012. doi:

ARVO Annual Meeting Abstract May 2006

Suppression and Regression of Choroidal Neovascularization by Systemic Administration of an 5ß1 Integrin Antagonist

N. Umeda; S. Kachi; H. Akiyama; G. Zahn; R. Stragies; P.A. Campochiaro

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):899. doi:

ARVO Annual Meeting Abstract May 2006

Delivery of Angioinhibitory Genes Using the VMD2 Promoter in Lentiviral Vectors Results in Selective Expression in RPE and Inhibition of Choroidal Neovascularization

S. Kachi; K. Binley; N. Umeda; H. Akiyama; K. Yokoi; M. Kachi; W. Xiao; M. Espa; S. Naylor; P.A. Campochiaro

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):906. doi:

ARVO Annual Meeting Abstract May 2006

Inhibition of Laser–Induced Choroidal Neovascularization in Mice Using Antisense Oligonucleotides Directed Against HIF–1 or HIF–1ß

T.W. Lauer; S.F. Hackett; R. Formica; K. Yokoi; N.H. Khu; S. Henry; P.A. Campochiaro

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):1428. doi:

ARVO Annual Meeting Abstract May 2006

Physiological Dissection of an Interstrain Difference in Susceptibility to Ischemic Retinopathy in Mice

R.C. Symons; W.H. Xiao; Y.Y. Gong; M.E. Swaim; P.A. Campochiaro

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):1431. doi:

ARVO Annual Meeting Abstract May 2006

TNF Is Critical for Retinal Leukostasis Mediated by VEGF, IL–1ß, and PAF and for Blood–Retinal Barrier (BRB) Breakdown in Ischemic Retinopathy

S.A. Vinores; W.–H. Xiao; J. Shen; P.A. Campochiaro

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):1723. doi:

ARVO Annual Meeting Abstract May 2006

Engineered Zinc Finger Protein Transcription factors as a Potential Therapy for Ocular Neovascularization

H.S. Zhang; S. Kachi; M. Kachi; P.–Q. Liu; H. Akiyama; N. Umeda; K. Yokoi; S. Hackett; P.D. Gregory; P.A. Campochiaro

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):1786. doi:

ARVO Annual Meeting Abstract May 2006

Development of a Sensor for Oxidative Stress in Retinal Pigmented Epithelial (RPE) Cells

M.L. Krause; J.–K. Shen; Y.–J. Chen; X.–R. Yang; M. Swaim; A. Symons; P.A. Campochiaro

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):2022. doi:

ARVO Annual Meeting Abstract May 2006

Iron–Mediated Retinal Degeneration: Evidence for Cone Selectivity

B.S. Rogers; R.C. A. Symons; Y.Y. Gong; J. Shen; W.H. Xiao; S. Kachi; P.A. Campochiaro

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):2047. doi:

ARVO Annual Meeting Abstract May 2006

Results of a Phase I, Dose–Escalation, Safety, Tolerability, and Bioactivity Study of Intravitreous VEGF Trap in Patients With Neovascular Age–Related Macular Degeneration

Q.D. Nguyen; S.M. Shah; D. Browning; P. Sonkin; H. Hudson; K. Chu; K. Rich; A. Lucas; J. Cedarbaum; P.A. Campochiaro

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):2144. doi:

ARVO Annual Meeting Abstract May 2006

A Double–Masked, Placebo–Controlled, Safety, and Tolerability Study of Intravenous VEGF Trap in Patients With Diabetic Macular Edema

S.M. Shah; Q.D. Nguyen; S. Harriprisad; K. Chu; N. Holekamp; J. Buskey; D. Nadler; J. Cederbaum; P.A. Campochiaro

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):3850. doi:

ARVO Annual Meeting Abstract May 2006

Screening for Photoreceptor–Survival Genes by Microarray Analysis

X. Liu; P.A. Campochiaro; R. Adler; D.J. Zack

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):4812. doi:

ARVO Annual Meeting Abstract May 2006

Results of an Open Label Phase 1/2 Study Assessing the Effects of Multiple Intravitreous Injections of Ranibizumab in Patients With Diabetic Macular Edema

P.A. Campochiaro; Q.D. Nguyen; S. Tatlipinar; S.M. Shah; J.A. Haller; P. Singletary; D.V. Do; J. Handa

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):5443. doi:

ARVO Annual Meeting Abstract May 2006

SOD1, but Not SOD3, Protects Against Retinal Degeneration Induced by Paraquat or Hyperoxia

A. Dong; M. Krause; H. Akiyama; J. Shen; L. Lu; S. Hackett; L. Hong; P.A. Campochiaro

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):5883. doi:

ARVO Annual Meeting Abstract May 2005

The Iron Carrier Transferrin Is Upregulated in Retinas From Patients With Age–Related Macular Degeneration

R. Wong; I. Chowers; T.I. Dentchev; R.H. Farkas; T.L. Gunatilaka; P.A. Campochiaro; C.A. Curcio; D.J. Zack; J.L. Dunaief

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):3017. doi:

ARVO Annual Meeting Abstract May 2005

Impact of Optical Coherence Tomography on Surgical Decision–Making in Epiretinal Membrane and Vitreo–Macular Traction

D.V. Do; M. Cho; Q.D. Nguyen; S.M. Shah; J.T. Handa; P.A. Campochiaro; I. Zimmer–Galler; J.U. Sung; J.A. Haller

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):3629. doi:

ARVO Annual Meeting Abstract May 2005

Expression of a Constitutively Active Form of HIF–1 in Photoreceptors Causes Retinal and Subretinal Neovascularization

S.F. Hackett; T.W. Lauer; C.J. Weitz; P.A. Campochiaro

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):4192. doi:

ARVO Annual Meeting Abstract May 2005

Angiopoietin 1 Prevents Retinal Detachment in an Aggressive Model of Proliferative Retinopathy, but Has No Effect on Established Neovascularization

N. Umeda; H. Nambu; S. Kachi; Y. Oshima; H. Akiyama; R. Nambu; P.A. Campochiaro

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):4193. doi:

ARVO Annual Meeting Abstract May 2005

Characterization of the Effects of 2'–MOE Antisense Oligonucleotides on mRNA Levels in Mice After Intravitreal Injection

S.P. Henry; Y. Saisin; H. Akiyama; E.G. Marcusson; T.M. Vincent; P.A. Campochiaro

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):4659. doi:

1 2 3

Next 20 Results »

Advertisement